WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

1. The World Health Organization has launched a global initiative to reduce the 15-to-20-year mortality gap for individuals with schizophrenia by 2030.

2. This effort prioritizes the integration of mandatory cardiovascular and metabolic screenings into psychiatric care to treat preventable physical conditions.

The World Health Organization and Psychiatric Times have brought renewed attention this April to the life expectancy gap affecting people living with schizophrenia. This gap, often ranging from 15 to 20 years, is largely driven by untreated physical health conditions such as cardiovascular disease and diabetes. It highlights a longstanding disconnect between mental health care and general medical care. According to the WHO’s latest fact sheets, individuals with schizophrenia face a significantly higher risk of premature mortality, often from preventable causes. The new initiative aims to shift how care is delivered by embedding routine physical health screening into psychiatric settings. This approach reflects a growing recognition that mental and physical health cannot be treated in isolation. Research discussed through integrated care models emphasizes the importance of coordinated management of cardiovascular risk in this population. The plan includes targets for monitoring weight, blood pressure, and lipid levels during routine visits. There is also a focus on addressing lifestyle factors such as smoking and physical inactivity, which are disproportionately common in this group. These changes could have a meaningful impact if implemented consistently across health systems. At the same time, challenges around access, funding, and workforce capacity remain. The initiative signals a broader shift toward equity in health outcomes for individuals with severe mental illness.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.